These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 6252164)
1. Cefotaxime in the treatment of severe paediatric infections. Papadatos CJ; Kafetzis DA; Kanarios J J Antimicrob Chemother; 1980 Sep; 6 Suppl A():243-8. PubMed ID: 6252164 [No Abstract] [Full Text] [Related]
2. The evaluation of efficacy and safety of cefotaxime: a review of 2500 cases. Young JP; Husson JM; Bruch K; Blomer RJ; Savopoulos C J Antimicrob Chemother; 1980 Sep; 6 Suppl A():293-300. PubMed ID: 6252175 [No Abstract] [Full Text] [Related]
3. Consensus report: antimicrobial therapy for bacterial meningitis in infants and children. McCracken GH; Nelson JD; Kaplan SL; Overturf GD; Rodriguez WJ; Steele RW Pediatr Infect Dis J; 1987 Jun; 6(6):501-5. PubMed ID: 3615064 [No Abstract] [Full Text] [Related]
4. Cefotaxime therapy in children with serious infections associated with reduced host defense mechanisms. López EL; Bonesana NF; Rubeglio E; Schugurensky A; Sommersguter G; Grinstein S J Antimicrob Chemother; 1980 Sep; 6 Suppl A():249-53. PubMed ID: 6252165 [No Abstract] [Full Text] [Related]
5. Efficacy of ceftriaxone in treatment of serious childhood infections. Chadwick EG; Connor EM; Shulman ST; Yogev R J Pediatr; 1983 Jul; 103(1):141-5. PubMed ID: 6306193 [No Abstract] [Full Text] [Related]
6. Cefotaxime in children: efficacy, tolerance and effect on the intestinal bacterial flora. Lambert-Zechovsky N; Aufrant C; Bingen E; Blum C; Proux MC; Mathieu H J Antimicrob Chemother; 1980 Sep; 6 Suppl A():235-42. PubMed ID: 6252163 [No Abstract] [Full Text] [Related]
7. Management of severe systemic infections caused by multiple resistant organisms. Shah PM; Helm EB; Stille W J Antimicrob Chemother; 1980 Sep; 6 Suppl A():269-72. PubMed ID: 6252169 [No Abstract] [Full Text] [Related]
9. [Rational parameters in the treatment of bacterial meningitis with modern cephalosporins]. Brückner O; Trautmann M Infection; 1987; 15 Suppl 4():S214-9. PubMed ID: 3312038 [TBL] [Abstract][Full Text] [Related]
10. Ceftriaxone: increasing the half-life and activity of third generation cephalosporins. Steele RW Pediatr Infect Dis; 1985; 4(2):188-91. PubMed ID: 3885182 [No Abstract] [Full Text] [Related]
11. Cefotaxime for treatment of gram-negative bacterial meningitis in infants and children. Feldstein TJ; Uden DL; Larson TA Pediatr Infect Dis J; 1987 May; 6(5):471-5. PubMed ID: 3601495 [No Abstract] [Full Text] [Related]
12. Cefotaxime and meningitis. Shah PM Lancet; 1980 Mar; 1(8166):490-1. PubMed ID: 6102223 [No Abstract] [Full Text] [Related]
13. Cefotaxime in the treatment of prophylaxis of surgical infections. Wittmann DH; Jones RN; Malledant J; Privitera G J Chemother; 1997 May; 9 Suppl 2():19-33. PubMed ID: 9248973 [TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation of 6059-S in children, particularly in the treatment of bacterial meningitis (author's transl)]. Kobayashi Y; Haruta T; Kuroki S; Okura K; Fujiwara T; Morikawa Y Jpn J Antibiot; 1981 Apr; 34(4):587-98. PubMed ID: 6457167 [No Abstract] [Full Text] [Related]
15. [Cefotaxime in the therapy of purulent meningitis in childhood]. Bozinović D; Dvorzak I; Kuzmanović N; Grljusić V Lijec Vjesn; 1987 Oct; 109(10):391-6. PubMed ID: 3669882 [No Abstract] [Full Text] [Related]
16. Efficacy and safety of cefotaxime in the management of pediatric infections. Jacobs RF Infection; 1991; 19 Suppl 6():S330-6. PubMed ID: 1791079 [TBL] [Abstract][Full Text] [Related]
17. The new cephalosporins for the treatment of bacterial meningitis in children and neonates. Bégué P G Ital Chemioter; 1985; 32(2):521-4. PubMed ID: 3833598 [No Abstract] [Full Text] [Related]
18. Cefotaxime treatment of meningitis in children. Sow A J Antimicrob Chemother; 1984 Sep; 14 Suppl B():191-4. PubMed ID: 6094439 [TBL] [Abstract][Full Text] [Related]